drugset / Trial / NCT02378688
Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objectives of the study are: * To evaluate the safety and tolerability of MT-1303 in subjects with moderate to severe active Crohn's Disease(CD) * To evaluate the clinical efficacy of MT-1303 in subjects with moderate to severe active CD.
Timeline
- Start
- 2015-03
- Primary completion
- 2016-10
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | amiselimod | Small molecule | — | — |